Strategic Project & Portfolio Management for Pharma

More Information

20th Annual

Strategic Project & Portfolio Management for Pharma

27 - 29 January 2021

Live Streaming and On-Demand

What do you hope to learn from others by attending the event?

Our mission at Bayer is Health for All. Hunger for None. To further this, the Bayer Pharma Research ambition is to bring meaningful therapies to patients in need and continuously increase the pipeline value with more impactful innovation balanced across value and risk. Strategic Project and Portfolio Management is aiming to improve the output of high quality assets through better portfolio decision making and supported by state-of-the-art portfolio assessment and prioritization tools. In a rapidly changing environment it is not possible that one company or let alone one person has all the best answers. We all need to connect to other professionals in Pharma but also other industries to continuously evolve our thinking.

What is the biggest challenge in portfolio management in a world redefined by Covid 19?

We need to ensure to progress towards our strategic goals in a rapidly evolving environment; what worked in the past will certainly not work anymore in future. So now more than ever we have to put the right enablers in place to stay successful—an innovation focus combined with speed, flexibility and agility. And our talent, tools, and processes need to be ever-evolving to make this happen.

What are the key ingredients to success in strategic management and modelling in times of uncertainty?

Based on an assessment of future trends and discovery approaches, we have to determine how research needs to evolve and set value-based portfolio strategies. Within this frame we then need to ensure high quality decision making, focus on highest value assets, and cultivation of the capabilities we need in the future. Pressure testing of key elements with external experts and internal stakeholders to gain further insights ensures we were on the right path and allows to adapt where necessary going forward. Additionally, we need to have the right level of detail—exhibiting the discipline every day to focus on the essential science and value drivers, and stripping out the unnecessary.

What are the main levers for effective forecasting and portfolio decision-making?

Effective portfolio decision making requires incorporation of the right value and risk criteria, transparency on portfolio diversity (e.g. fit to disease area strategies, value/risk profile, maturity) and understanding the output which can be achieved within the available resource frame. Informed by throughput modelling and capability assessments resources can actively be allocated to portfolio priorities, and through best possible resource allocation flexibility we can react to change.

An interview with:

Dr. Heike Gielen-Haertwig Head of Portfolio Management Preclinical Research at Bayer

Follow us on Social Media!

With increased impact from the pandemic, pharma and biotech companies are under pressure to deliver results and adapt to new business realities with a fresh approach to PPM. Covid-19 and its aftermath have brought into focus the need to prioritize better and deliver results under increased budget constraints. Project selection and portfolio valuation are crucial tools for PPM managers to understand their competitive advantage, core portfolio values and market forecasts, and to align with their strategic corporate objectives.

This marcus evans unique conference will discuss how you can articulate your priorities better in a COVID-19 environment, and how to overcome increased reporting overload and drive a positive impact in your portfolio strategy. We will explore strategic modeling in times of uncertainty, and how to align R&D and Commercial with an integrated data strategy that takes advantage of AI and machine learning opportunities. By attending this event, you will learn how to do efficient scenario prediction to achieve the right risk-benefit balance in your portfolio, and how in the long run, you can adapt to the new normal with resilient portfolio performance informed by sound-decision making.

Your safety is our top priority.

Can’t physically attend this conference?

Don’t worry we have you covered! If your ability to travel is restricted we know your appetite for key business insights remains so our Live+ digital platform enables you to fully participate in the event remotely. Of course it provides access to live online streams of all session, but much more than that, it ensures you are able to engage with speakers directly allowing you to participate in Q&A, relevant breakout groups as well as event polling and other insights and resources delivered during the event. We realise interacting with other delegates is key to your event experience, so our innovate online solution allows you to set up online meetings with other virtual and physical attendees throughout the event; ensuring you still walk away with those key contacts that can make a tangible difference to you and your business. The platform will continue to host all event content on-demand for you to re-visit and continue to access for up to 6 months post event.

Your content. Your way.

About the conference

We would be delighted to provide you with more information on the conference agenda. Please fill in your details below and we will be in touch.

Heike Gielen-Haertwig is the Head of Portfolio Management Preclinical Research at Bayer Pharmaceuticals. She holds a PhD in Organic Chemistry from the RWTH Aachen, Germany and has 20 years of pharmaceutical industry experience in the fields of Research and Development project and portfolio management. After having completed her PhD, she held a position as postdoctoral research fellow at the University of Cambridge, UK. Heike joined Bayer in 1999 as head of laboratory and project leader for Research projects with focus on cardiovascular diseases and since then held several positions of increasing responsibility as project leader for Development projects as well as in R&D Portfolio Management, Portfolio Analytics, and Strategy.

To view the Conference Agenda, click HERE!

For all enquiries regarding speaking, sponsoring and attending this conference contact:

Yiota Andreou
Email: Yiotaa@marcusevanscy.com
Telephone: +357 22849 404
Fax: +357 22 849 394